Rare diseases
Investigational molecules
Locations
Study on the Effects of Ecopipam Hydrochloride for Children and Adolescents with Tourette's Disorder
PolandStudy Comparing DZD9008 and Chemotherapy for First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Mutation
PolandStudy of Chemotherapy With Pembrolizumab and Olaparib for Patients With Advanced Epithelial Ovarian Cancer Without BRCA Mutation
PolandStudy comparing tarlatamab with topotecan in patients with relapsed small cell lung cancer after first-line chemotherapy
PolandStudy of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy
PolandStudy Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma
PolandStudy on Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low to Intermediate Risk Myelodysplastic Syndromes Needing Blood Transfusions
PolandStudy on the Long-Term Safety of Ecopipam Hydrochloride Tablets for Children, Adolescents, and Adults with Tourette's Disorder
PolandStudy on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
PolandStudy of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery
PolandStudy of Pembrolizumab, Paclitaxel, and Bevacizumab for Patients with Platinum-Resistant Recurrent Ovarian Cancer
PolandStudy of Pembrolizumab and Lenvatinib for Patients with Advanced Non-Clear Cell Kidney Cancer
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
